世界の乱用薬物検査サービス市場2021-2028:薬物種類別(大麻/マリファナ、オピオイド、コカイン、アルコール、LSD、アンフェタミン、メタンフェタミン)、地域別

◆英語タイトル:Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, LSD, Amphetamine & Methamphetamine), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA022
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:125
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の乱用薬物検査サービス市場規模が2028年までに38億ドルに達すると予測しています。2021年から2028年までに年平均5.2%成長する見通しです。本調査レポートでは、乱用薬物検査サービスの世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、薬物種類別(アルコール、大麻/マリファナ、コカイン、オピオイド、アンフェタミン・メタンフェタミン)分析、地域別分析、企業情報など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・乱用薬物検査サービスの世界市場規模:薬物種類別(アルコール、大麻/マリファナ、コカイン、オピオイド、アンフェタミン・メタンフェタミン)
・乱用薬物検査サービスの世界市場規模:地域別
・企業情報
【レポートの概要】

Drug Of Abuse Testing Services Market Growth & Trends

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities. On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs. However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health. In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs. This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Drug Of Abuse Testing Services Market Report Highlights

• By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.

• The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths

• North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country

• Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs

• COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Drug of Abuse Testing Services Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of substance abuse & growing demand for its treatment
3.3.1.2 Increase in government initiatives to monitor substance abuse
3.3.1.3 Stringent law mandating alcohol and drug testing
3.3.2 Market Restraint Analysis
3.3.2.1 Drug testing is considered a violation of privacy rights in some countries
3.3.2.2 Lack of awareness about sepsis
3.3.3 Market Opportunity Analysis
3.3.3.1 Focus on development of innovative testing services
3.4 Drug of Abuse Testing Services Market Analysis Tools
3.4.1 Industry analysis – Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
Chapter 4 Drug of Abuse Testing Services Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2020
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Drug of Abuse Testing Services Market: Drug Type Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Drug Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Drug of Abuse Testing Services Market, by Drug Type, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Alcohol
5.5.1.1 Alcohol Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Cannabis/Marijuana
5.5.2.1 Cannabis/Marijuana Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Cocaine
5.5.3.1 Cocaine Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.4 Opioids
5.5.4.1 Opioids Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.5 Amphetamine & Methamphetamine
5.5.5.1 Amphetamine & Methamphetamine Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.6 LSD
5.5.6.1 LSD Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.7 Other Drug Types
5.5.7.1 Other Drug Types Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 6 Drug of Abuse Testing Services Market: Regional Estimates & Trend Analysis
6.1 Regional Market Snapshot
6.2 Regional Market Share and Leading Players, 2020
6.2.1 North America
6.2.2 Europe
6.2.3 Latin America
6.2.4 Asia Pacific
6.2.5 Middle East & Africa
6.3 Market Share Analysis by Country, 2020
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.2.1 U.K.
6.3.2.2 Germany
6.3.2.3 Spain
6.3.2.4 France
6.3.2.5 Italy
6.3.3 Latin America
6.3.3.1 Brazil
6.3.3.2 Mexico
6.3.3.3 Chile
6.3.4 Asia Pacific
6.3.4.1 Japan
6.3.4.2 China
6.3.4.3 India
6.3.5 Middle East & Africa
6.3.5.1 South Africa
6.3.5.2 Saudi Arabia
6.3.5.3 UAE
6.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.4.1 North America
6.4.2 Europe
6.4.3 Latin America
6.4.4 Asia Pacific
6.4.5 Middle East & Africa
6.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
6.5.1 North America
6.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.1.2 U.S.
6.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.1.3 Canada
6.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.2 Europe
6.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.2.2 U.K.
6.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.2.3 Germany
6.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.2.4 Spain
6.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.2.5 France
6.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.2.6 Italy
6.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.3 Latin America
6.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.3.2 Brazil
6.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.3.3 Mexico
6.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.3.4 Chile
6.5.3.4.1 Chile Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.4 Asia Pacific
6.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.4.2 Japan
6.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.4.3 China
6.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.4.4 India
6.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.5 Middle East & Africa
6.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
6.5.5.2 South Africa
6.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.5.3 Saudi Arabia
6.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
6.5.5.4 UAE
6.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
Chapter 7 Company Profile
7.1 Company Profiles
7.1.1 Quest Diagnostics, Inc.
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Abbott Laboratories
7.1.2.1 Company overview
7.1.2.2 Financial Performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Clinical Reference Laboratory, Inc.
7.1.3.1 Company overview
7.1.3.2 Financial Performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Laboratory Corporation of America Holdings
7.1.4.1 Company overview
7.1.4.2 Financial Performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Cordant Health Solutions
7.1.5.1 Company overview
7.1.5.2 Financial Performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Legacy Medical Services, LLC.
7.1.6.1 Company overview
7.1.6.2 Financial Performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 DrugScan
7.1.7.1 Company overview
7.1.7.2 Financial Performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Omega Laboratories, Inc.
7.1.8.1 Company overview
7.1.8.2 Financial Performance
7.1.8.3 Product benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Psychemedics Corporation
7.1.9.1 Company overview
7.1.9.2 Financial Performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Millennium Health
7.1.10.1 Company overview
7.1.10.2 Financial Performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 Mayo Clinic Laboratories
7.1.11.1 Company overview
7.1.11.2 Financial Performance
7.1.11.3 Product benchmarking
7.1.11.4 Strategic initiatives
7.1.12 Precision Diagnostics
7.1.12.1 Company overview
7.1.12.2 Financial Performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives
7.1.13 American Substance Abuse Professionals, Inc.
7.1.13.1 Company overview
7.1.13.2 Financial Performance
7.1.13.3 Product benchmarking
7.1.13.4 Strategic initiatives
7.1.14 United States Drug Testing Laboratories, Inc. (USDTL)
7.1.14.1 Company overview
7.1.14.2 Financial Performance
7.1.14.3 Product benchmarking
7.1.14.4 Strategic initiatives
7.1.15 LGC Group
7.1.15.1 Company overview
7.1.15.2 Financial Performance
7.1.15.3 Product benchmarking
7.1.15.4 Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America drug of abuse testing services market estimates and forecasts, by country, 2016 - 2028 (USD Million)
Table 4 North America drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 5 U.S. drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 6 Canada drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 7 Europe drug of abuse testing services market estimates and forecasts, by country, 2016 - 2028 (USD Million)
Table 8 Europe drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 9 Germany drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 10 U.K. drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 11 France drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 12 Italy drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 13 Spain drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 14 Asia Pacific drug of abuse testing services market estimates and forecasts, by country, 2016 - 2028 (USD Million)
Table 15 Asia Pacific drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 16 Japan drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 17 China drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 18 India drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 19 Latin America drug of abuse testing services market estimates and forecasts, by country, 2016 - 2028 (USD Million)
Table 20 Latin America drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 21 Brazil drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 22 Mexico drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 23 Chile drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 24 MEA drug of abuse testing services market estimates and forecasts, by country, 2016 - 2028 (USD Million)
Table 25 MEA drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 26 South Africa drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 27 Saudi Arabia drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 28 UAE drug of abuse testing services market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020 (USD Million)
Fig. 9 Drug of abuse testing services market segmentation
Fig. 10 Penetration & growth prospect mapping for drug type, 2020
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Company/competition categorization (key innovators, market leaders, emerging players)
Fig. 14 Strategy framework
Fig. 15 Market participation categorization
Fig. 16 Company position analysis
Fig. 17 Drug of abuse testing services market: Drug type outlook and key takeaways
Fig. 18 Drug of abuse testing services market: Drug type movement analysis
Fig. 19 Alcohol market, 2016 - 2028 (USD Million)
Fig. 20 Cannabis/marijuana market, 2016 - 2028 (USD Million)
Fig. 21 Cocaine market, 2016 - 2028 (USD Million)
Fig. 22 Opioids market, 2016 - 2028 (USD Million)
Fig. 23 Amphetamine & methamphetamine market, 2016 - 2028 (USD Million)
Fig. 24 LSD market, 2016 - 2028 (USD Million)
Fig. 25 Others market, 2016 - 2028 (USD Million)
Fig. 26 Drug of abuse testing services market: Regional outlook and key takeaways
Fig. 27 Drug of abuse testing services market: Regional movement analysis
Fig. 28 North America
Fig. 29 North America drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 30 U.S.
Fig. 31 U.S. drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Canada
Fig. 33 Canada drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 Europe
Fig. 35 Europe drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 Germany
Fig. 37 Germany drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 U.K.
Fig. 39 U.K. drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 France
Fig. 41 France drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 Italy
Fig. 43 Italy drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 Spain
Fig. 45 Spain drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Asia Pacific
Fig. 47 Asia Pacific drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Japan
Fig. 49 Japan drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 China
Fig. 51 China drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 India
Fig. 53 India drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 Latin America
Fig. 55 Latin America drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 56 Brazil
Fig. 57 Brazil drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 58 Mexico
Fig. 59 Mexico drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 60 Chile
Fig. 61 Chile drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 62 MEA
Fig. 63 MEA drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 64 South Africa
Fig. 65 South Africa drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 66 Saudi Arabia
Fig. 67 Saudi Arabia drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 68 UAE
Fig. 69 UAE drug of abuse testing services market estimates and forecast, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の乱用薬物検査サービス市場2021-2028:薬物種類別(大麻/マリファナ、オピオイド、コカイン、アルコール、LSD、アンフェタミン、メタンフェタミン)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆